FDA Approves Agamree (vamorolone) for the Treatment of Duchenne Muscular Dystrophy

CORAL GABLES, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ( " Catalyst " or " Company " ) (Nasdaq: CPRX) today reported that Santhera Pharmaceuticals ( " Santhera " ) has obtained U.S. Food and Drug Administration ( " FDA " ) approval...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news